**For the first time, researchers have developed a non-intrusive way to generate large quantities of stem cells using only a small amount of blood** **The stem cells can repair cells damaged as a result of vascular diseases, which has the potential to prevent blindness and reverse the need for amputations** A discovery by researchers at
The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue engineering, and broader global regenerative medicine sector trends and metrics in the first quarter of 2019. By further curating information provided by ARM’s data partner Informa, the quarterly data report details
A discovery opens the possibility of one day restoring loss of vision by activating the retina’s ability to regenerate. Researchers at Baylor College of Medicine, the Cardiovascular Research Institute and the Texas Heart Institutereveal in the journal Cell Reports that although the mammalian retina – a layer of specialized nerve cells that mediates vision and is located on the back
As a lung transplant surgeon, Matt Bacchetta has watched countless patients wait for an organ, only to not get one. About 80 percent of donor lungs are not in good enough to shape to use. Now Bacchetta and a team of researchers from Columbia University in New York City have shown that they can repair
For the first time, scientists have used genetically modified viruses to treat a patient fighting an antibiotic-resistant infection. Isabelle Carnell-Holdaway, 17, began the experimental treatment after doctors lost all hope. She was struggling with a life-threateninginfection after a lung transplant. With the new treatment, she has not been completely cured. But the Faversham, England, teenager has
Regenerative medicine—a field that includes stem cells, bioengineered tissues, and gene therapies—holds great potential. In November 2017, the Food and Drug Administration updated its regulatory framework for these products. Peter Marks, who leads the agency’s Center for Biologics Evaluation and Research (CBER), about the framework gave this interview. Q: What led FDA to update its regulatory framework
In this interview with Bruce Levine Ph.D. (University of Pennsylvania, PA, USA) we find out about his talk on constantly enhancing and improving engineered T cells, which was presented recently at the American Association for Cancer Research (AACR) Annual Meeting (March 29–April 3, 2019, Atlanta, GA, USA). In addition, we also asked about his thoughts
The hospital is going to be a very different place in the 2020s than it has been up until now. Increasingly, doctors and nurses are going to be incorporating mobile devices and wireless technologies into patient health care, and this is called mobile health or mHealth. In a 2018 study done by Zebra Technologies, it was estimated that by
Patients with type 2 diabetes who receive intensive treatment to keep their blood pressure levels at 130/80 mm Hg or below experience fewer heart attacks, strokes, and other diabetes complications, according to a study published online April 29 in Hypertension. Faisal Rahman, M.D., of the Ciccarone Center for the Prevention of Heart Disease at the Johns
Many of Europe’s major research universities are ignoring rules that require them to make public the results of clinical trials. A report published on 30 April found that the results of only 162 of 940 clinical trials (17%) that were due to be published by 1 April had been posted on the European Union’s trials register. The 30
